Back to Search
Start Over
Optimizing dose-dense regimens for early-stage breast cancer.
- Source :
- Nature Reviews Clinical Oncology; Dec2010, Vol. 7 Issue 12, p678-679, 2p, 1 Chart
- Publication Year :
- 2010
-
Abstract
- The article discusses the randomised phase III trial conducted by Arbeitsgemeinschaft Gynakologische Onkologie (AGO) Breast Study Group on women with high-risk early-stage breast cancer. The patients were assigned to sequential intense dose-dense (IDD) chemotherapy with epirubicin, paclitaxel and cyclophosphamide. A brief background on the use of adjuvant chemotherapy for women with early-stage breast cancer is presented, as well as a chart showing the efficacy of dose-dense chemotherapy.
Details
- Language :
- English
- ISSN :
- 17594774
- Volume :
- 7
- Issue :
- 12
- Database :
- Supplemental Index
- Journal :
- Nature Reviews Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 56672995
- Full Text :
- https://doi.org/10.1038/nrclinonc.2010.188